Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David A. Knorr
Toxicity of an Fc-Engineered Anti-Cd40 Antibody Is Abrogated by Intratumoral Injection and Results in Durable Antitumor Immunity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody
Journal of Immunology
Allergy
Immunology
CD40/anti-CD40 Antibody Complexes Which Illustrate Agonist and Antagonist Structural Switches
BMC Molecular and Cell Biology
Cell Biology
Molecular Biology
Embryo Implantation Is Blocked by Intraperitoneal Injection With Anti-Lif Antibody in Mice
Journal of Reproduction and Development
Animal Science
Zoology
Effective Antibody Therapy Induces Host-Protective Antitumor Immunity That Is Augmented by TLR4 Agonist Treatment
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Antagonism of VEGF by Genetically Engineered Dendritic Cells Is Essential to Induce Antitumor Immunity Against Malignant Ascites
Molecular Cancer Therapeutics
Cancer Research
Oncology
CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Delivery of NKG2D Ligand Using an Anti-Her2 Antibody-Nkg2d Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response
Cancer Research
Cancer Research
Oncology
Intratumoral Injection of an Adenovirus Expressing Interleukin 2 Induces Regression and Immunity in a Murine Breast Cancer Model.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Anti-Tumor Efficacy of 3C23K, a Glyco-Engineered Humanized Anti-Misrii Antibody, in an Ovarian Cancer Model Is Mainly Mediated by Engagement of Immune Effector Cells
Oncotarget
Oncology
